title: Acral sclerosis due to interferon-alpha-2b in chronic myelogenous leukemia.
authors.affiliation: Department of Hematology, School of Medicine, Ege University, TR-35100 Bornova, Izmir, Turkey. gsaydam@med.ege.edu.tr
authors.forename: Guray
authors.initials: G
authors.lastname: Saydam
authors.forename: Devrim
authors.initials: D
authors.lastname: Bozkurt
authors.forename: Fahri
authors.initials: F
authors.lastname: Sahin
authors.forename: Safak
authors.initials: S
authors.lastname: Yuksel
authors.forename: Mine
authors.initials: M
authors.lastname: Hekimgil
authors.forename: Serdar Bedii
authors.initials: SB
authors.lastname: Omay
authors.forename: Filiz
authors.initials: F
authors.lastname: Buyukkececi
mesh_terms: D000328:Adult; D005385:Fingers; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D008297:Male; D009336:Necrosis; D011994:Recombinant Proteins; D012598:Sclerosis / Q000139:chemically induced* / Q000473:pathology
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins